MAPRE1 and breast carcinoma: Together, these findings indicate that EB1 promotes paclitaxel sensitivity in breast cancer cells by enhancing the ability of paclitaxel to stimulate microtubule assembly and stabilization and then cause mitotic arrest and apoptosis.